Literature DB >> 29185824

Comparison Between High-Pressure Processing and Chemical Extraction: Astaxanthin Yield From Six Species of Shrimp Carapace.

Cicy Irna1, Irwandi Jaswir1,2, Rashidi Othman2,3, Dzun Noraini Jimat1.   

Abstract

Astaxanthin is one of the main carotenoid pigments. It has beneficial effects on the immune system of the human body due to its powerful antioxidant properties. The application of this bioactive compound can be found to be significant in the food, pharmaceutical, and cosmetics industries. The aim of this research was to investigate astaxanthin yield from six species of Malaysian shrimp carapace. Six types of shrimp species-Parapenaeopsis sculptili, Metapenaeus lysianassa, Macrobrachium rosenbergii, Metapenaeopsis hardwickii, Penaeus merguiensis, and Penaeus monodon-were used to investigate total carotenoid content and astaxanthin yield. The investigation was carried out using chemical extraction and high-pressure processing (HPP) methods at 210 MPa, for a period of 10 min with a solvent mixture of acetone and methanol (7:3, v/v). HPP was proven to have a significant impact in increasing the total carotenoid content and astaxanthin yield. The highest total carotenoid content and astaxanthin yield is shown to be contained in the Penaeus monodon species. Total carotenoid was increased from 46.95 µg/ml using chemical extraction to 68.26 µg/ml using HPP; yield of astaxanthin was increased from 29.44 µg/gdw using chemical extraction to 59.9744 µg/gdw using HPP. Therefore, comparison between the HPP and chemical extraction methods showed that HPP is more advantageous with higher astaxanthin yield, higher quality, and shorter extraction time.

Entities:  

Keywords:  astaxanthin; carotenoid; high-pressure processing; shrimp

Mesh:

Substances:

Year:  2017        PMID: 29185824     DOI: 10.1080/19390211.2017.1387885

Source DB:  PubMed          Journal:  J Diet Suppl        ISSN: 1939-0211


  1 in total

Review 1.  Astaxanthin from Crustaceans and Their Byproducts: A Bioactive Metabolite Candidate for Therapeutic Application.

Authors:  Vida Šimat; Nikheel Bhojraj Rathod; Martina Čagalj; Imen Hamed; Ivana Generalić Mekinić
Journal:  Mar Drugs       Date:  2022-03-12       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.